tiprankstipranks
Trending News
More News >
ArriVent BioPharma, Inc. (AVBP)
NASDAQ:AVBP
US Market

ArriVent BioPharma, Inc. (AVBP) Income Statement

Compare
58 Followers

ArriVent BioPharma, Inc. Income Statement

Last quarter (Q3 2025), ArriVent BioPharma, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, ArriVent BioPharma, Inc.'s net income was $-34.98M. See ArriVent BioPharma, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 94.31M$ 74.59M$ 36.91M$ 8.70M
Depreciation and Amortization
$ 0.00$ 0.00$ 36.91M$ 0.00
EBITDA
$ -80.49M$ -74.59M$ 0.00$ -51.61M
Operating Income
$ -94.31M$ -74.59M$ -36.91M$ -8.70M
Other Income/Expenses
$ 13.82M$ 5.26M$ 0.00$ -42.91M
Pretax Income
$ -80.49M$ -69.33M$ -36.91M$ -51.61M
Net Income
$ -80.49M$ -69.33M$ -36.91M$ -51.61M
Per Share Metrics
Basic EPS
$ -2.56$ -2.17$ -1.10$ -40.44
Diluted EPS
$ -2.56$ -2.17$ -1.10$ -40.44
Weighted Average Shares Outstanding
31.47M 31.96M 33.49M 1.28M
Weighted Average Shares Outstanding (Diluted)
31.47M 31.96M 33.49M 1.28M
Currency in USD

ArriVent BioPharma, Inc. Earnings and Revenue History